About Us

Eastern Link Capital is a China focused private equity fund registered with Asset Management Association of China(AMAC). EL Capital manages four funds, with committed capital from leading institutional investors, including the prestige joint venture fund of funds of China Development Bank and Suzhou Industrial Park, Beijing Municipal Government Guidance Fund and China Create Capital. We invest in late stage companies and middle market buyout in consumer, healthcare service & medical devices and technology. Our partners' hands-on working experience with the local capital market and the fund's unique investment strategy in helping our portfolio companies access the dynamic China's local capital market will generate high returns for our investors. EL Capital is headquartered in Beijing with additional offices in Suzhou, Boston and Seattle.MORE >

Investment Strategy

EL Capital intends to optimize the fund's return via its investing team's experience, engage in the dynamic China capital market situation and differentiate the fund's investment strategy with a combination of late stage and middle market buyout investments in three sectors: consumer, healthcare service & medical devices and technology.

Investment Criteria: EL Capital is targeting high growth companies seeking capital to expand revenue and accelerate profitability. In addition, we seek companies with excellent executive teams and a scalable business earnings model with an expanding customer base, attractive market growth, potential for high profitability and convenient future exit opportunities. Companies are expected to be within the top 5 position in their market segments of $500 million in revenues or more. Also,investments in the companies could be conveniently exited by through an IPO or M&A event to financial or strategic buyers within a three to five year period.

Healthcare Consumer Technology
MORE >

Investment Team

Company News

  • 【易联资本被投企业】元年科技-携中台战略获数亿投资

    2020-10-16
    疫情之下,估值水平的整体打折已经成为投资大佬们的共识。然而,对于少数被疫情进一步证实发展潜力的公司,估值不仅不降,反而一飞冲天。易联资本投资项目——北京元年科技股份有限公司(简称:元年科技)就是这少数公司中的一家。
    Details...
  • 易联资本在“2019母基金年会”上荣获两项大奖

    2019-12-31
    易联资本荣获“2019年中国最佳新锐基金TOP30”和“2019年中国最佳创业投资基金TOP100”两项大奖。
    Details...
  • 易联资本荣获“2019中国最佳投资基金TOP20”

    2019-08-01
    易联资本荣获“2019中国最佳新锐基金TOP20”,易联资本合伙人卢胜利受邀出席本次活动。
    Details...
  • 易联资本投资动物疫苗领军企业国药动保

    2019-06-19
    2019年5月,易联资本投资国内动物疫苗和动物保健产业领军企业国药动保公司;易联资本在生物医疗领域相继投资了北大未名医药(002581)、恒升医学(835615)、北京启慧医疗、杭州好络维医疗等企业。
    Details...
  • 易联资本创始合伙人侯玉东受邀出席中国基金合伙人融资峰会圆桌论坛

    2018-07-20
    本届创业周继续以“汇聚全球智慧、打造创业天堂”为主题,2018年7月10日到12日在苏州举行。
    Details...

Portfolio

X

官方微信公众号